Validating the Use of Blood Transcriptomic Signatures for the Diagnosis of Active Pulmonary Tuberculosis
NCT04995406 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 722
Last updated 2024-03-08
Summary
ISIT-TB Prototype is a diagnostic assay based on a transcriptional blood signature suggestive of the detection of Mycobacterium tuberculosis.
Conditions
- TUBERCULOSIS, PULMONARY
Interventions
- DIAGNOSTIC_TEST
-
ISIT-TB prototype
Diagnostic assay able to identify active tuberculosis using a patient blood sample processed on an automatized system within an hour
Sponsors & Collaborators
-
BioMérieux
lead INDUSTRY
Principal Investigators
-
Keertan Dheda, Pr · University of Cape Town
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-01-03
- Primary Completion
- 2023-05-01
- Completion
- 2023-12-31
Countries
- South Africa
Study Locations
More Related Trials
-
Evaluation of Different Diagnostic Methods of Tuberculosis in Assiut University Hospitals
NCT06666972 ·Status: NOT_YET_RECRUITING
-
Development of Automated Molecular Diagnostic Platform for Tuberculosis Diagnosis (New Assay TB)
NCT04988984 ·Status: UNKNOWN
-
Tuberculosis Prevention for HIV Infected Adults
NCT00057122 ·Status: COMPLETED ·Phase: PHASE3
-
Integrated Discovery and Development of Innovative TB Diagnostics
NCT06624501 ·Status: COMPLETED
-
Safety and Efficacy of RUTI® With the Standard of Treatment for Tuberculosis
NCT05455112 ·Status: COMPLETED ·Phase: PHASE2
-
Identifcation of Biomarkers for Active Pulmonary Tuberculosis
NCT04490746 ·Status: UNKNOWN
-
Performance Evaluation of TB Breath- and Cough-testing Platforms
NCT03025516 ·Status: UNKNOWN
-
Evaluation of Host Biomarker-based Point-of-care Tests for Targeted Screening for Active TB
NCT03350048 ·Status: COMPLETED
-
Evaluation of CRISPR-based Test for the Rapid Identification of TB in Pulmonary Tuberculosis Suspects
NCT04074369 ·Status: UNKNOWN
-
Comparison of Diagnostic Performance of C-Tb to QuantiFERON®-TB, in Combination With a Safety Assessment of C-Tb vs Tuberculin PPD RT23 SSI
NCT01631266 ·Status: COMPLETED ·Phase: PHASE3
-
Point-of-care Pharmacogenomic Testing to Optimize Isoniazid Dosing for Tuberculosis Prevention
NCT05413551 ·Status: COMPLETED ·Phase: PHASE1
-
A Retrospective Cohort Study to Develop Markers for TB Severity and Treatment Progress
NCT05477966 ·Status: UNKNOWN
-
Phase IV Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein
NCT05746611 ·Status: COMPLETED ·Phase: PHASE4
-
Use TST and QFT-RD1 Test to Monitor the Tuberculous Infection in Patients, Close Contact People and Health Care Workers
NCT00311220 ·Status: UNKNOWN ·Phase: PHASE4
-
Immunocompetent Versus Immunocompromised Tuberculosis (TB) Patients
NCT06709157 ·Status: NOT_YET_RECRUITING
-
The Role of Apoptosis Associated Markers in Pathogenesis of Pulmonary Tuberculosis
NCT01676155 ·Status: UNKNOWN
-
Time-to-Detection in Culture of Mycobacterium Tuberculosis
NCT05568368 ·Status: COMPLETED
-
Impact of New Immunological Diagnosis Tests of Latent Tuberculosis Before Anti TNF Therapy
NCT00811343 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in Pulmonary Tuberculosis Suspects
NCT01587469 ·Status: COMPLETED
-
QuantiFERON®-TB Gold In-Tube for the Diagnosis of Tuberculosis Infection in Contact Tracing Study.
NCT01223534 ·Status: COMPLETED ·Phase: PHASE4
-
Innovation in Tuberculosis
NCT04002869 ·Status: UNKNOWN
-
The Clinical Utility of QuantiFERON in the Diagnosis of Active Tuberculosis
NCT00982969 ·Status: COMPLETED
-
Determining Risk in Latent Tuberculosis
NCT01571739 ·Status: TERMINATED
-
Diagnosis of Active and Latent TB Infection With IFN-y Assays in African Children
NCT00456469 ·Status: UNKNOWN
-
Evaluation of the Practice of Three Morning Sputa on Separate Days for Diagnosis of Mtb
NCT00212550 ·Status: COMPLETED